Literature DB >> 148372

Salpingostomy by microsurgery.

V Gomel.   

Abstract

Salpingostomy for hydrosalpinx was carried out using a microsurgical technique. The postoperative patency rate was over 90%. Among the 41 patients followed for more than 1 year, 29% have had one or more intrauterine pregnancies and 27% have had live births. The ectopic gestation rate was 12%. All of the tubal gestations occurred in the 1st postoperative year whereas 60% of the intrauterine pregnancies occurred after the 1st year, suggesting a degree of restoration in the mucosa and the musculature of the oviduct with the re-establishment of patency and the passage of time.

Entities:  

Mesh:

Year:  1978        PMID: 148372     DOI: 10.1016/s0015-0282(16)43210-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  In vitro fertilization versus reconstructive tubal surgery.

Authors:  V Gomel; P J Taylor
Journal:  J Assist Reprod Genet       Date:  1992-08       Impact factor: 3.412

2.  In vitro fertilization in humans and embryo transfer.

Authors:  P T Hewlett
Journal:  Can Med Assoc J       Date:  1982-08-01       Impact factor: 8.262

3.  Surgical reversal of tubal ligation.

Authors:  P J Taylor
Journal:  Can Fam Physician       Date:  1979-05       Impact factor: 3.275

Review 4.  Drugs in the treatment of female infertility. Recent advances.

Authors:  M M Quigley
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

5.  The role of antibiotic prophylaxis for tubal microsurgery.

Authors:  G S Letterie; M Hibbert
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

6.  Factors influencing the success of microsurgery for distal tubal occlusion.

Authors:  T J Laatikainen; A K Tenhunen; P K Venesmaa; D L Apter
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

Review 7.  Is There Still a Place for Reconstructive Surgery in Distal Tubal Disease?

Authors:  Bogdan Obrzut; Marzanna Obrzut
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.